2018
DOI: 10.1111/nmo.13390
|View full text |Cite
|
Sign up to set email alerts
|

Rasagiline, an inhibitor of MAO‐B, decreases colonic motility through elevating colonic dopamine content

Abstract: Monoamine oxidase-B is abundant in the colonic muscular layer including myenteric plexus of rat and human. Long-term administration of rasagiline can increase colonic DA thereby inhibiting colonic motility, suggesting that colonic MAO-B could be a potential drug target for colonic dysmotility.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 44 publications
1
12
0
Order By: Relevance
“…In DAT knockout mice or rats treated with rasagiline, an inhibitor of the main dopamine‐degrading enzyme monoamine oxidase‐B, the resultant increases in tissue concentration of dopamine is associated with attenuation of colonic motility 24,28 . In the present study, an acute increase in the synaptic dopamine level with the DAT inhibitor GBR 12909 caused a reduction in the frequency of propagating peristaltic waves (Figure 3I, J), suggesting that excessive “synaptic” dopamine inhibits colonic peristalsis (Figure S2C).…”
Section: Discussionsupporting
confidence: 54%
See 1 more Smart Citation
“…In DAT knockout mice or rats treated with rasagiline, an inhibitor of the main dopamine‐degrading enzyme monoamine oxidase‐B, the resultant increases in tissue concentration of dopamine is associated with attenuation of colonic motility 24,28 . In the present study, an acute increase in the synaptic dopamine level with the DAT inhibitor GBR 12909 caused a reduction in the frequency of propagating peristaltic waves (Figure 3I, J), suggesting that excessive “synaptic” dopamine inhibits colonic peristalsis (Figure S2C).…”
Section: Discussionsupporting
confidence: 54%
“…In colonic muscle strips, the D 1 ‐like receptor antagonist SCH 23390 increases the frequency and amplitude of spontaneous phasic contractions, 7,8,10,23,24 and also enhanced cholinergic nerve‐mediated contractions 10 . Thus, it was envisaged that D 1 ‐like receptor blockade exhibits prokinetic effect on peristaltic waves.…”
Section: Discussionmentioning
confidence: 99%
“…This coumarin, C18 or 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2 h-chromen-2-one, is an inhibitor of monoamine oxidase-B, which is abundant in the muscular layers of the rats' colon. Its administration increases dopamine which inhibits colon motility 26 , which suggest mobility of the colon in DCS. This deserves to be confirmed.…”
Section: Expression Of Metabolites Indicating An Alteration Of the Homentioning
confidence: 99%
“…In our study, β-PEA and Klamin ® were applied directly on the intestinal muscle strips, so their activity was similar. However, if considering oral intake, pure β-PEA would rapidly be degraded by selective MAO-B enzymes, highly expressed in muscular layer and myenteric plexus of human colon [47]. On the contrary, Klamin ® , besides its natural β-PEA content, also contains molecules, such as AFA-phycocyanins, Mycosporine-like aminoacids (MAAs), and phycochrome, that have shown to be the most powerful natural selective MAO-B enzymes inhibitors [36].…”
Section: Discussionmentioning
confidence: 99%